Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
JNT-517 by Jnana Therapeutics for Phenylketonuria (PKU): Likelihood of Approval
JNT-517 is under clinical development by Jnana Therapeutics and currently in Phase II for Phenylketonuria (PKU). According to GlobalData, Phase...